Panadol Osteo to stay delisted

The PBAC has reaffirmed its decision that Panadol Osteo should be delisted. “The PBAC assessed the issues raised in the correspondence, but did not consider that there was any basis to revisit its earlier recommendations in this regard,” it has said in outlining the outcome of its consideration on the fate of the medicine. The